| 英文别名 |
Gusacitinib;Gusacitinib [INN];gusacitinib (proposed INN);ASN002;GTPL10000;4801QYW816;example 189 [WO2013028818A1];4-Piperidineacetonitrile, 1-(5,6-dihydro-4-((4-(4-hydroxy-1-piperidinyl)phenyl)amino)-5-oxopyrimido(4,5-d)pyridazin-2-yl)-;ASN-002;2-(1-(4-((4-(4-Hydroxypiperidin-1-yl)phenyl)amino)-5-oxo-5,6-dihydropyrimido[4,5-d]pyridazin-2-yl)piperidin-4-yl)acetonitrile;Gusacitinib [USAN];EN-3351;UNII-4801QYW816;AKOS040741172;EN3351;BCP31675;Gusacitinib (ASN-002)?;NSC-818003;SCHEMBL14717111;2-[1-(4-{[4-(4-hydroxypiperidin-1-yl)phenyl]amino}-5-oxo-3H-pyrimido[4,5-d]pyridazin-2-yl)piperidin-4-yl]acetonitrile;CHEMBL4594275;HY-103018;F78024;Gusacitinib [USAN:INN];1425381-60-7;1-(4-(4-(4-Hydroxy-piperidin-1-yl)-phenylamino)-5-oxo-5,6-dihydro-pyrimido(4,5-D)pyridazin-2-yl)-piperidin-4-YL-acetonitrile;2-(1-(4-(4-(4-Hydroxypiperidin-1-yl)phenylamino)-5-oxo-5,6-dihydropyrimido[5,4-d]pyridazin-2-yl)piperidin-4-yl)acetonitrile;GUSACITINIB [WHO-DD];D11676;WHO 10976;NSC818003;DB-133043;ASN-002; ASN 002; ASN002;BDBM50595921;CS-0023113;2-[1-[4-[4-(4-hydroxypiperidin-1-yl)anilino]-5-oxo-6H-pyrimido[4,5-d]pyridazin-2-yl]piperidin-4-yl]acetonitrile;EX-A2668;MS-28452;Gusacitinib (USAN/INN) |